ELYRIA, Ohio–(BUSINESS WIRE)–Aug. 2, 2006–Invacare (NYSE:IVC) announced today the signing of a multi-year distribution agreement with AEIOMed, Inc. Invacare now has exclusive distribution rights to AEIOMed’s current and soon-to-be-released line of sleep-related medical devices.
AEIOMed is a leader in customer-driven design, development and production of medical devices for consumers with sleep disorders. The company introduced several innovative sleep products, including the first truly compact, completely integrated CPAP System. This CPAP is recognized for its small size and portable battery module, which makes it perfect for sleep patients that require the flexibility and mobility associated with an active lifestyle. AEIOMed also developed the very latest in patient interface design, which includes a nasal pillow that provides a stable and unobtrusive interface with nothing touching the patient’s face except at the nares. Both products now will be privately labeled and distributed by Invacare.
“Invacare is rapidly adding to its sleep product line and is on its way to becoming the third major player in the sleep industry,” said Ann MacGregor, vice president and category manager, Invacare Sleep Division. “We’re doing this by building our sleep infrastructure through people with a strong history in the industry. Combining our current sleep lineup with AEIOMed’s experienced sleep team, Invacare will offer the best in clinical technology and comfort through a full line of compliance driven sleep products that providers and sleep labs should not miss.”
Invacare will begin to distribute AEIOMed products under private label by September 1, 2006. These products will be on display September 19-21 in Atlanta, Georgia at Medtrade(R) 2006, the home healthcare industry’s largest trade show of the year.
“We are excited about this opportunity to partner with the market leader in home and long-term care medical products,” states Steve Bordewick, chief executive officer and founder of AEIOMed. “This agreement gives AEIOMed access to Invacare’s roster of over 100 direct sales reps and it gives Invacare access to AEIOMed’s integrated CPAP system and experienced management team. We will both be strengthened through this agreement and expect it to be a wonderful combination for the companies – and our customers.”
AEIOMed, Inc., headquartered in Minneapolis, Minnesota, integrates technology, the input from customers, and the creativity of its employees, to provide innovative, quality products that improve the lives of people with sleep disorders. For more information about the company and its products, visit AEIOMed’s website at www.aeiomed.com.
Invacare (NYSE:IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The company has 6,100 associates and markets its products in 80 countries around the world. For more information about the company and its products, visit Invacare’s website at www.invacare.com.
Contact:
Invacare
Lara Mahoney, 440-329-6393
or
AEIOMed, Inc.
Holly Larkin, 612-455-0574